KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Times Interest Earned (2018 - 2025)

Vertex Pharmaceuticals (VRTX) has 10 years of Times Interest Earned data on record, last reported at $365.42 in Q4 2025.

  • For Q4 2025, Times Interest Earned changed 0.27% year-over-year to $365.42; the TTM value through Dec 2025 reached $313.78, up 4222.68%, while the annual FY2025 figure was $313.78, 4222.68% up from the prior year.
  • Times Interest Earned reached $365.42 in Q4 2025 per VRTX's latest filing, up from $359.45 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $366.43 in Q4 2024 and bottomed at -$355.02 in Q2 2024.
  • Average Times Interest Earned over 3 years is $170.07, with a median of $179.44 recorded in 2024.
  • The widest YoY moves for Times Interest Earned: up 292.93% in 2024, down 487.4% in 2024.
  • A 3-year view of Times Interest Earned shows it stood at $93.25 in 2023, then skyrocketed by 292.93% to $366.43 in 2024, then fell by 0.27% to $365.42 in 2025.
  • Per Business Quant database, its latest 3 readings for Times Interest Earned were $365.42 in Q4 2025, $359.45 in Q3 2025, and $311.11 in Q2 2025.